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Abstract
 
Platelet adhesion and aggregation at sites of vascular injury is crucial for hemostasis but may lead
to arterial occlusion in the setting of atherosclerosis and precipitate diseases such as myocardial
infarction. A current hypothesis suggests that platelet glycoprotein (GP) Ib interaction with von
Willebrand factor recruits flowing platelets to the injured vessel wall, where subendothelial
fibrillar collagens support their firm adhesion and activation. However, so far this hypothesis has
 
not been tested in vivo
 
. 
 
Here, we demonstrate by intravital fluorescence microscopy of the
mouse carotid artery that inhibition or absence of the major platelet collagen receptor, GPVI,
abolishes platelet–vessel wall interactions after endothelial denudation. Unexpectedly, inhibition
of GPVI by the monoclonal antibody JAQ1 reduced platelet tethering to the subendothelium
 
by 
 
 
 
89%. In addition, stable arrest and aggregation of platelets was virtually abolished under
these conditions. Using different models of arterial injury, the strict requirement for GPVI in
these processes was confirmed in GPVI-deficient mice, where platelets also failed to adhere and
aggregate on the damaged vessel wall. These findings reveal an unexpected role of GPVI in the
initiation of platelet attachment at sites of vascular injury and unequivocally identify platelet–
collagen interactions (via GPVI) as the major determinant of arterial thrombus formation
 
.
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Introduction
 
Platelet adhesion and aggregation is essential to limit blood
loss at sites of vascular injury but may also lead to arterial
occlusion and irreversible tissue damage after disruption of
the atherosclerotic plaque. The first platelet response to
vascular injury is adhesion to the exposed subendothelial
matrix, which triggers subsequent platelet aggregation. A
current hypothesis supported by numerous in vitro studies
suggests that the interaction of glycoprotein (GP)
 
*
 
Ib-V-IX
with von Willebrand factor (vWf) recruits flowing platelets
to the injured vessel wall (1), where they interact with ex-
posed extracellular matrix proteins resulting in firm adhe-
sion and thrombus growth (2, 3). Although several of the
macromolecular components of the subendothelial layer
such as laminin, fibronectin, and vWf all provide a suitable
substrate for platelet adhesion, fibrillar collagen is consid-
ered the most thrombogenic constituent of the vascular
subendothelium as it not only supports platelet adhesion
but also acts as a strong activator of platelets in vitro (3, 4).
However, the in vivo relevance of platelet–collagen inter-
actions in the setting of arterial thrombosis has not been es-
tablished. This might be explained by the complexity of
the platelet–collagen interaction, which involves a variety
of different receptors and signaling pathways making the in
 
vivo inhibition of this process very difficult. Besides
GPIb-V-IX and integrin 
 
 
 
IIb
 
 
 
3
 
, which interact indirectly
with collagen via vWf (5), a large number of collagen re-
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Role of GPVI in Arterial Thrombosis
 
ceptors have been identified on platelets, including most
importantly integrin 
 
 
 
2
 
 
 
1 
 
(6), GPV (7), and GPVI (8).
Only recently, GPVI has been established as the central
platelet collagen receptor that is essential for platelet adhe-
sion and aggregation on immobilized collagen in vitro
 
,
 
 as it
mediates the activation of different adhesive receptors, in-
cluding integrins 
 
 
 
IIb
 
 
 
3 
 
and 
 
 
 
2
 
 
 
1 
 
(9–12). GPVI is a 60–65-
kD type I transmembrane GP belonging to the immuno-
globulin superfamily (13, 14) that forms a complex with
the FcR 
 
  
 
chain at the cell surface in human and mouse
platelets (9, 10). Signaling through GPVI occurs via a path-
way similar to that used by immunoreceptors as revealed by
the tyrosine phosphorylation of the FcR 
 
  
 
chain immu-
noreceptor tyrosine-based activation motif by a src-like ki-
nase (15). The mAb JAQ1 (10) blocks the major collagen
binding site on mouse GPVI and inhibits firm platelet ad-
hesion to collagen under low and high shear flow condi-
tions (12). In vivo application of JAQ1 induces virtually
complete internalization and degradation of GPVI on
mouse platelets resulting in a “GPVI knockout”–like phe-
notype for at least 2 wk. Such GPVI-depleted mice have
significantly prolonged bleeding times and their platelets
fail to respond to collagen but not to other agonists (11).
Despite its essential role in collagen-induced activation of
platelets, there has been only very limited evidence for a
role of GPVI as a direct adhesion receptor (14, 16).
In this study we investigated the in vivo significance of
platelet–collagen interactions in the dynamic process of
platelet adhesion and aggregation at sites of arterial injury.
We show that inhibition or deletion of GPVI virtually ab-
rogates stable platelet adhesion and aggregation after endo-
thelial denudation of the carotid artery in mice. Very
unexpectedly, we found that tethering/slow surface trans-
location of platelets was also strongly inhibited in the ab-
sence of functional GPVI. These findings reveal a crucial
role of GPVI in the initiation of platelet recruitment at sites
of vascular injury and provide the first in vivo evidence that
platelet–collagen interactions are of paramount importance
during arterial thrombus formation
 
.
 
Materials and Methods
 
Animals.
 
Specific pathogen-free C57BL/6J mice were ob-
tained from Charles River Laboratories. For experiments, 12-wk-
old male mice were used. All experimental procedures performed
on animals were approved by the German legislation on protec-
tion of animals.
 
mAbs.
 
mAbs against GPVI (JAQ1) and GPIb
 
  
 
(p0p/B) were
generated as previously described (10). Fab fragments from JAQ1
and p0p/B were also generated as previously described (11). Irrel-
evant control rat IgG and FITC-conjugated hamster anti–
 
 
 
1 in-
tegrin (Ha31/8) was obtained from BD Biosciences. The follow-
ing antibodies were produced and modified in our laboratory (17)
and used for flow cytometry: JON1-PE (anti-GPIIb/IIIa), p0p4-
PE (anti-GPIb
 
 
 
), p0p6-FITC (anti-GPIX), DOM1-FITC (anti-
GPV), and LEN1-FITC (anti-GPIa).
 
Generation of GPVI-deficient Mice.
 
To generate mice lacking
GPVI, C57BL6/J wild-type mice were injected with 100 
 
 
 
g
JAQ1 intracardially (11). Animals were used for in vivo assess-
 
ment of platelet adhesion on day 5 after mAb injection. Absence
of GPVI expression on platelets was verified by Western blot
analysis and flow cytometry.
 
Flow Cytometry.
 
Heparinized whole blood, obtained from
wild-type C57BL6/J or GPVI-depleted mice was diluted 1:30 with
modified Tyrodes-Hepes buffer (134 mM NaCl, 0.34 mM
Na
 
2
 
HPO
 
4
 
, 2.9 mM KCl, 12 mM NaHCO
 
3
 
, 20 mM Hepes, 5 mM
glucose, and 1 mM CaCl
 
2
 
, pH 6.6). The samples were incubated
with fluorophore-labeled antibodies for 10 min at room tempera-
ture and directly analyzed on a FACScalibur™
 
 
 
(Becton Dickinson).
 
Preparation of Platelets for Intravital Microscopy.
 
Wild-type or
GPVI-deficient platelets were isolated from whole blood as pre-
viously described (18) and labeled with 5-carboxyfluorescein di-
acetate succinimidyl ester (DCF). The DCF-labeled platelet sus-
pension was adjusted to a final concentration of 200 
 
  
 
10
 
6
 
platelets/250 
 
 
 
l. Where indicated, fluorescent wild-type platelets
were preincubated with 50 
 
 
 
g/ml anti-GPVI (JAQ1) Fab frag-
ments, which do not induce any detectable platelet signaling (19).
In a separate set of experiments, platelets were preincubated with
50 
 
 
 
g/ml anti-GPIb
 
  
 
(p0p/B) Fab fragments for 10 min to ex-
amine the role of GPIb
 
  
 
for platelet recruitment after endothelial
denudation. The pretreated platelets together with the Fab frag-
ments were infused into wild-type recipient mice and platelet ad-
hesion was assessed before and after carotid injury by in vivo
video microscopy, as described below.
 
Carotid Ligation and Assessment of Platelet Adhesion and Aggrega-
tion by Intravital Microscopy.
 
Wild-type C57BL6/J or GPVI-defi-
cient mice were anesthetized by intraperitoneal injection of a
solution of midazolame (5 mg/kg body weight; Ratiopharm),
medetomidine (0.5 mg/kg body weight; Pfizer), and fentanyl
(0.05 mg/kg body weight; CuraMed Pharma GmbH). Polyethyl-
ene catheters (Portex) were implanted into the right jugular vein
and 200 
 
  
 
10
 
6
 
/250 
 
 
 
l fluorescent platelets were infused intrave-
nously. The right common carotid artery was dissected free and
ligated vigorously near the carotid bifurcation for 5 min to induce
vascular injury. Before and after vascular injury, the fluorescent
platelets were visualized in situ by in vivo video microscopy of
the right common carotid artery. Platelet–vessel wall interactions
were monitored using a Zeiss Axiotech microscope (20
 
  
 
water
immersion objective, W 20
 
 
 
/0.5; Carl Zeiss MicroImaging,
Inc.) with a 100-W HBO mercury lamp for epi-illumination. All
videotaped images were evaluated using a computer-assisted im-
age analysis program (Cap Image 7.4; provided by Dr. Zeintl;
references 18 and 20). Tethered platelets were defined as all cells
establishing initial contact with the vessel wall, followed by slow
surface translocation at a velocity significantly lower than the
centerline velocity, or by firm adhesion. Their numbers are given
as cells per mm
 
2 
 
endothelial surface. The number of adherent
platelets was assessed by counting the cells that did not move or
detach from the endothelial surface within 10 s. The number of
platelet aggregates at the site of vascular injury was also quantified
and is presented per mm
 
2
 
.
 
Scanning Electron Microscopy.
 
After intravital video fluores-
cence microscopy, the carotid artery was perfused with PBS at
37
 
 
 
C for 1 min, followed by perfusion fixation with phosphate-
buffered glutaraldehyde (1% vol/vol). The carotid artery was ex-
cised, opened longitudinally, additionally fixed by immersion in
1% PBS-buffered glutaraldehyde for 12 h, dehydrated in ethanol,
and processed by critical point drying with CO
 
2
 
. The carotid ar-
tery specimens were then oriented with the lumen exposed,
mounted with carbon paint, sputter coated with platinum, and
examined using a field emission scanning electron microscope
(JSM-6300F; Jeol Ltd.).T
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Assessment of Arterial Thrombosis after Ferric Chloride Exposure.
 
Vascular injury of the carotid artery was induced by local applica-
tion of ferric chloride (FeCl
 
3
 
) essentially as described by Fay et al.
(21). In brief, control or GPVI-depleted C57BL/6J mice were
anesthetized and fluorescence-tagged control or GPVI-deficient
platelets were infused intravenously into the jugular vein of un-
treated or GPVI-depleted recipients, respectively. Thereafter, the
common carotid artery was dissected free and a filter paper
(0.5 
 
  
 
1.0 mm) saturated with 10% FeCl
 
3 
 
was applied to the ad-
ventitial surface of the vessel, as previously described (21). The
time to thrombotic occlusion of the carotid artery downstream of
the site of injury (
 
n 
 
  
 
10 per group) was defined as the time re-
quired for complete arrest of blood flow in the center of the ves-
sel (platelet flow velocity 0 m/s) after removal of the filter paper.
 
Determination of Platelet Recruitment after Wire-induced Arterial
Denudation.
 
Wire-induced endothelial disruption was per-
formed according to a method described by Lindner et al. (22). In
brief, GPVI-depleted C57BL/6J mice were generated as de-
scribed above (
 
n 
 
  
 
12). Mice pretreated with 100 
 
 
 
g irrelevant
control IgG (
 
n 
 
  
 
6) or PBS (
 
n 
 
  
 
12) served as controls. 5 d after
mAb injection, the animals were anesthetized and platelets were
isolated from control or GPVI-depleted mice and labeled with
DCF (see above). In the recipient mice, the right carotid artery
was exposed via a midline neck incision. The common, external,
and internal carotid arteries were identified, the right internal ca-
rotid artery was looped proximally and tied off distally with 8–0
silk suture (Ethicon). Additional 8–0 silk ties were looped round
the common and external carotid arteries for temporary vascular
control during the procedure. A transverse arteriotomy was made
in the right internal carotid artery and a 0.014-in flexible angio-
plasty guidewire was introduced and advanced 1 cm to the aortic
arch. Endothelial denudation injury of the right common carotid
artery was performed by wire withdrawal with rotating motion to
ensure uniform and complete endothelial denudation. After re-
moval of the wire, the right internal carotid artery was tied off and
platelet–vessel wall interactions were visualized at the site of injury
by in vivo video fluorescence microscopy as described above.
 
Results and Discussion
 
To test the biological significance of platelet–collagen in-
teractions in the processes of adhesion and aggregation in
vivo, we assessed platelet–vessel wall interactions after vas-
Figure 1. Platelet adhesion and aggregation after vascular injury of the
common carotid artery in C57BL/6J mice in vivo. (a) Scanning electron
micrographs of carotid arteries before (left) and 2 h after vascular injury
(right). Endothelial denudation induces platelet adhesion and aggregation,
resulting in the formation of a platelet-rich (lower right) thrombus. (b)
Platelet–endothelial cell interactions 5 min after vascular injury were inves-
tigated by in vivo fluorescence microscopy of the common carotid artery
in situ (solid columns). Animals without vascular injury served as controls
(open columns). The left and right panels summarize platelet tethering and
firm platelet adhesion, respectively, of eight experiments per group. Plate-
lets were classified according to their interaction with the endothelial cell
lining as previously described (refer to Materials and Methods) and are
given per mm2 of vessel surface. Mean   SEM. *, significant difference
compared with control, P   0.05. (c) Platelet aggregation after vascular in-
jury was determined by fluorescence microscopy in vivo (solid columns).
Animals without vascular injury served as controls (open columns). Mean  
SEM and n   8 each group. *, significant difference compared with wild-type mice, P   0.05. The microphotographs (right) show representative in vivo
fluorescence microscopy images in control animals (top) or after vascular injury (bottom). White arrows indicate adherent platelets. Bars, 50  m.T
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cular injury of the mouse carotid artery. Vigorous ligation
of the carotid artery consistently caused complete loss of
the endothelial cell layer and initiated platelet adhesion at
the site of injury, as assessed by scanning electron micros-
copy (Fig. 1 a). Next, we used in vivo fluorescence micros-
copy (18, 20) to directly visualize and quantify the dynamic
process of platelet accumulation after vascular injury. Nu-
merous platelets were tethered to the vascular wall within
the first minutes after endothelial denudation (4725 
 
  
 
239
platelets/mm
 
2
 
). Virtually all platelets establishing contact
with the subendothelium initially exhibited a slow surface
translocation of the “stop-start” type (23). As we observed
transition from initial slow surface translocation to irrevers-
ible platelet adhesion in 88% of all platelets (4.182 
 
  
 
253
platelets/mm
 
2
 
; Fig. 1 b), platelet arrest remained transient
in only 12% (543 
 
  
 
32 platelets/mm
 
2
 
). Once firm arrest
was established, adherent platelets recruited additional
platelets from the circulation, resulting in aggregate forma-
tion (Fig. 1 c). Similar characteristics of platelet recruitment
have been obtained earlier with immobilized collagen in
vitro (5). In contrast, only few platelets were tethered to
the intact vascular wall under physiological conditions (P 
 
 
 
0.05 vs. vascular injury) and 
 
 
 
100% of these platelets were
displaced from the vascular wall without firm arrest (P 
 
 
 
0.05 vs. vascular injury; Fig. 1, a–c).
Subendothelial fibrillar collagen has been proposed to be
of major importance for platelet adhesion and aggregation
at sites of vascular injury (2, 4, 24) as in vitro it strongly
supports platelet activation and adhesion. However, this
hypothesis has not been tested in vivo where various other
agonists and adhesion molecules might be involved in
thrombus formation. To directly test the in vivo relevance
of platelet–collagen interactions in arterial thrombus forma-
tion, we inhibited or deleted GPVI in vivo. The mAb
JAQ1 (10, 25) blocks the major collagen-binding site on
mouse GPVI and almost completely inhibits firm platelet
adhesion to immobilized fibrillar collagen under high shear
flow conditions in vitro (12). To study the effect of GPVI
inhibition in arterial thrombus formation, mice received
syngeneic, fluorescence-tagged platelets preincubated with
JAQ1 Fab fragments or isotype-matched control IgG and
carotid injury was induced as described above. Very unex-
pectedly, platelet tethering/slow surface translocation at
sites of endothelial denudation, a process thought to be
mediated solely by GPIb
 
  
 
interaction with immobilized
vWf (1, 3, 26, 27), was reduced by 89% (P 
 
  
 
0.05 vs. con-
trol IgG; Fig. 2 a) in the presence of JAQ1 Fab fragments.
In addition, stable platelet arrest was reduced by 93% in the
presence of JAQ1 (Fig. 2 a). We observed transition from
initial tethering/slow surface translocation to irreversible
Figure 2. Inhibition of GPVI abrogates platelet adhesion and aggrega-
tion after vascular injury. (a) Platelet adhesion after vascular injury was de-
termined by intravital video fluorescence microscopy. Fluorescent plate-
lets were preincubated with 50  g/ml anti-GPVI (JAQ1) Fab fragments
or control rat IgG. Platelets without mAb preincubation served as con-
trol. The left and right panels summarize transient and firm platelet adhe-
sion, respectively. Mean   SEM and n   8 each group. *, significant
difference compared with control, P   0.05. (b) The percentage of plate-
lets establishing irreversible adhesion after initial tethering/slow surface
translocation is illustrated. (c) Platelet aggregation after vascular injury in
vivo. Aggregation of platelets preincubated with tyrode, irrelevant rat
IgG, or anti-GPVI (JAQ1) was assessed by fluorescence microscopy as
previously described. Mean   SEM and n   8 each group. *, significant
difference compared with control, P   0.05. (d) The photomicrographs
show representative in vivo fluorescence microscopy images illustrating
platelet adhesion in the absence or presence of anti-GPVI Fab (JAQ1) or
control IgG. Bars, 30  m. (e) Inhibition of GPIb  abrogates platelet re-
cruitment after vascular injury. Platelets were incubated with 50  g/ml
anti-GPIb  Fab fragments (p0p/B) for 10 min. Platelets without mAb
preincubation served as control. The left and right panels summarize tran-
sient and firm platelet adhesion, respectively. Mean   SEM and n   6
each group. *, significant difference compared with control, P   0.05.T
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platelet adhesion in only 58% of those platelets establishing
initial contact with the subendothelial surface compared
with 89% with control IgG–pretreated platelets (P   0.05;
Fig. 2 b). Aggregation of adherent platelets was virtually
absent after pretreatment of platelets with JAQ1 Fab frag-
ments but not in the controls (P   0.05 vs. control; Fig. 2,
c and d). The unanticipated inhibitory effect of GPVI
blockade on tethering/slow surface translocation prompted
us to examine the role of GPIb  in this process. Mice re-
ceived fluorescence-tagged platelets preincubated with Fab
fragments of a function blocking antibody against GPIb 
(p0p/B) and carotid injury was induced as described above.
As shown in Fig. 2 e, this treatment resulted in a similarly
profound reduction in platelet tethering and firm adhesion
(and consequently also in aggregate formation) as anti-
GPVI treatment (see above) confirming the crucial role of
GPIb  for platelet attachment to the damaged vascular wall
under conditions of arterial shear. This finding strongly
suggested that both GPVI and GPIb  are required to re-
cruit platelets to the injured arterial wall in vivo.
Together, the results described above demonstrated for
the first time that direct platelet–collagen interactions are
essential for initial platelet tethering and subsequent stable
platelet adhesion and aggregation at sites of arterial injury.
In addition, these data identify GPVI as a key regulator in
this process whereas other surface receptors, most impor-
Figure 3. Platelet adhesion after endothelial denudation in GPVI-deficient mice. (a) JAQ1-treated mice lack GPVI. On the top, platelets from mice
pretreated with irrelevant control IgG or anti-GPVI (JAQ1) were stained for GPVI and GPIIb/IIIa (top) or GPIa and GPIb  (bottom) and directly ana-
lyzed on a FACScalibur™ is shown. Representative dot plots of six mice per group are presented. The expression levels of GPIIb/IIIa, GPIb-V-IX, and
GPIa/IIa were not significantly different between the two groups of mice (refer to Table I). On the bottom, whole platelet lysates from three control IgG
or JAQ1-treated mice separated by SDS-PAGE under nonreducing conditions and immunoblotted with FITC-labeled JAQ1, followed by incubation
with horseradish peroxidase–labeled rabbit anti–FITC antibody is shown. (b) Scanning electron micrographs of carotid arteries 2 h after vascular injury in
control animals or GPVI depleted. Endothelial denudation induced platelet adhesion and platelet aggregation in control animals. In contrast, only very
few platelets attached along the damaged vessel wall in GPVI-depleted mice. Subendothelial collagen fibers are visible along the denuded area. (c) Platelet
tethering and firm platelet adhesion, (d) transition from initial tethering to stable arrest (percentage of tethered platelets), and (e) platelet aggregation after
vascular injury of the carotid artery was determined in GPVI-deficient (JAQ1-pretreated mice) or control IgG–pretreated mice (for details refer to Mate-
rials and Methods). The panels summarize platelet adhesion (tethering and firm adhesion) and platelet aggregation in eight experiments per group. Mean  
SEM. *, significant difference compared with control IgG, P   0.05. (f) The photomicrographs show representative in vivo fluorescence microscopy im-
ages illustrating platelet adhesion in GPVI-deficient (JAQ1) and control IgG–treated mice. Bars, 30  m.T
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tantly GPIb-V-IX and  2 1, are not sufficient to initiate
platelet adhesion and aggregation on the subendothelium
in vivo.
The profound inhibition of platelet tethering by GPVI
blockade was surprising and suggested a previously unrecog-
nized function of this receptor in the very initial phase of
thrombus formation. To exclude the possibility that this ef-
fect was based on steric impairment of other receptors, e.g.
GPIb-V-IX, by surface-bound JAQ1, we generated GPVI-
deficient mice by injection of JAQ1 5 d before vascular in-
jury. As reported previously, such treatment induces virtu-
ally complete internalization and proteolytic degradation of
GPVI in circulating platelets, resulting in a GPVI knockout–
like phenotype for at least 2 wk (11). As illustrated in Fig. 3
a, GPVI was undetectable in platelets from JAQ1-treated
mice on day 5 after injection of 100  g/mouse JAQ1 but
not control IgG, whereas surface expression and function of
all other tested receptors, including GPIb-V-IX,  IIb 3, and
 2 1 was unchanged in both groups of mice, confirming
earlier results (Fig. 3 a and Table I; reference 11).
As shown by scanning electron microscopy, platelet ad-
hesion and aggregation after endothelial denudation of the
common carotid artery were virtually absent in GPVI-defi-
cient, but not in IgG-pretreated, mice (Fig. 3 b). Next, in
vivo video fluorescence microscopy was used to define
platelet adhesion dynamics after vascular injury in GPVI-
deficient mice (Fig. 3, c–f). The loss of GPVI profoundly
reduced tethering/slow surface translocation of platelets at
the site of vascular injury by 83% compared with IgG-pre-
treated mice (P   0.05). This GPVI-independent slow sur-
face translocation required vWf-GPIb –interaction as it was
abrogated by preincubation of the platelets with Fab frag-
ments of p0p/B (anti-GPIb ), confirming the critical role
of GPIb  in this process (not depicted). In the absence of
GPVI, stable platelet adhesion was reduced by  90% com-
pared with the (IgG-treated) control, whereas aggregation
of adherent platelets was virtually absent (Fig. 3, b–f). We
saw transition from platelet tethering to stable platelet adhe-
sion in only 58% of all platelets initially tethered to the site
of injury compared with 89% with control mAb–pretreated
platelets (P   0.05; Fig. 3 d), indicating that GPIb -depen-
dent surface translocation is not sufficient to promote stable
platelet adhesion and subsequent aggregation.
To further substantiate the role of GPVI in the process of
platelet recruitment after endothelial disruption, we next
examined platelet adhesion/aggregation using two addi-
tional models of arterial thrombosis. First, arterial injury
was induced in control or GPVI-depleted mice by local ad-
ministration of ferric chloride to the adventitial surface of
the carotid artery as previously described (21). Time to ar-
terial occlusion was monitored by in vivo fluorescence mi-
croscopy. As shown in Fig. 4, FeCl3 exposure resulted in a
rapid thrombotic response in control animals. 9 out of 10
carotid arteries showed complete occlusion after 235  
33 s. In contrast, arterial thrombus formation was dramati-
cally retarded in GPVI-deficient mice (P   0.05 vs. control
mice). In fact, 6 out of 10 GPVI-deficient mice did not
show arterial occlusion until 600 s after removal of the
FeCl3-saturated filter paper. In the remaining vessels, oc-
clusion was markedly delayed (356   55 s). These results
further support a crucial role of GPVI in the process of ar-
terial thrombus formation.
Next, we assessed platelet recruitment in the carotid ar-
tery after wire-induced endothelial disruption (22). As re-
ported earlier by Zhu et al. (28) and Lindner et al. (22),
vascular injury with a flexible wire consistently caused
complete endothelial denudation (unpublished data). In
untreated control animals and mice pretreated with irrele-
vant control IgG, disruption of the endothelial surface initi-
ated platelet tethering and adhesion as assessed in vivo by
video fluorescence microscopy (Fig. 5). Numerous platelets
were tethered to the vascular wall within the first minute
after endothelial denudation (11.495    1.283 tethered
platelets/mm2).  46% of all platelets establishing contact
with the subendothelium showed transition from initial
slow surface translocation to irreversible platelet adhesion
(5.266   915 firmly adherent platelets/mm2). Platelet ad-
hesion at the site of injury was associated with the forma-
tion of platelet aggregates attached to the site of injury.
Platelet adhesion dynamics in mice pretreated with irrele-
vant IgG did not differ significantly from untreated control
animals (13.521   2.519 and 5.474   1.575 tethered and
Table I. Surface Expression of GPs on Platelets from
JAQ1-treated Mice
Control JAQ1-treated (d5)
GPVI 58.8   6.4 5.7   0.5
GPIb  298.1   11.5 293.5   12.7
GPIX 326.9   14.7 323.4   13.9
GPV 176.9   15.0 169.9   16.4
GPIIb/IIIa 370.9   19.5 381.4   14.5
GPIa ( 2) 60.0   9.3 57.4   8.4
GPIIa ( 1) 223.9   15.4 230.8   18.3
Diluted whole blood from the indicated mice was incubated with fluoro-
phore-labeled antibodies at saturating concentrations for 10 min at room
temperature and platelets were analyzed directly. Results are expressed as
mean log fluorescence   SD for six mice per group.
Figure 4. Role of GPVI in
arterial thrombosis after ferric
chloride exposure. Vascular in-
jury of the carotid artery was in-
duced by local application of fer-
ric chloride on the carotid artery
in GPVI-deficient or control
mice. The time to thrombotic
occlusion of the carotid artery
downstream of the site of injury
(n   10 per group) was assessed
in vivo by video fluorescence
microscopy. Each symbol repre-
sents one experiment.T
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firmly adherent platelets/mm2, respectively). In contrast to
control animals, platelet tethering/slow surface transloca-
tion and firm adhesion at sites of wire-induced endothelial
denudation were reduced by 90 and 95% in GPVI-
depleted mice (P   0.05 vs. control mice; Fig. 5). We ob-
served transition from initial tethering/slow surface translo-
cation to irreversible platelet adhesion in only 24% of those
platelets establishing initial contact with the subendothelial
surface compared with 46% with control animals (P  
0.05). Aggregation of adherent platelets was virtually absent
in GPVI-deficient mice (P   0.05 vs. control; Fig. 5). To-
gether, these data add additional strong evidence to the
concept that GPVI-mediated direct platelet–collagen inter-
actions are essential for initial platelet tethering and subse-
quent stable platelet adhesion and aggregation at sites of ar-
terial injury.
Fibrillar collagen is a major constituent of the normal
vessel wall but also of atherosclerotic lesions (29). In the
process of atherogenesis, enhanced collagen synthesis by in-
timal smooth muscle cells and fibroblasts has been shown to
significantly contribute to luminal narrowing (30). Plaque
rupture or fissuring, either spontaneously or after balloon
angioplasty, results in exposure of collagen fibrils to the
flowing blood but their contribution to arterial thrombus
formation has been elusive. Platelets express a large number
of different collagen receptors, which made it very difficult
to identify the role of each of these receptors in the pro-
cesses of adhesion and activation in vitro. In addition, re-
agents suitable for specific inhibition of individual collagen
receptors in vivo have not been available. Only recently
has GPVI been identified as the central platelet receptor
that is essential for both adhesion and activation of platelets
on collagen in vitro (12). In contrast, the absence of other
major collagen receptors such as integrin  2 1 or GPV only
results in more subtle defects in the platelet–collagen inter-
action (7, 12, 31), suggesting that inhibition or deletion of
GPVI, but no other collagen receptor, is required to abro-
gate platelet collagen–interactions in vivo.
The results of this study provide the first definitive evi-
dence that subendothelial collagens are the major trigger of
arterial thrombus formation and reveal an unexpected
function of GPVI in platelet recruitment to the injured
vessel wall. The processes of platelet tethering and slow
surface translocation under conditions of elevated shear are
known to largely depend on GPIb  interaction with im-
mobilized vWf (1). In addition, a number of studies have
shown that GPIb  or even its NH2-terminal 45-kD do-
main, which carries the binding site for vWf, mediates
tethering of cells or coated beads, respectively, to a vWf-
coated surface under high shear flow conditions (32, 33).
Figure 5. Role of GPVI in the regulation of platelet
recruitment after wire injury of the carotid artery.
Wire-induced endothelial denudation of the carotid ar-
tery was induced in GPVI-deficient mice. Untreated
animals served as controls. The left shows representa-
tive in vivo fluorescence microscopy images illustrating
the time course of platelet recruitment to the site of
injury in control animals or GPVI-deficient mice
( 500). The right summarizes platelet tethering, firm
adhesion, and aggregate formation. Mean   SEM. *,
significant difference compared with control, P   0.05.T
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Together, these findings suggested that GPIb –vWf inter-
actions might be sufficient to establish the initial contact
and slow surface translocation of platelets at sites of vascular
injury. However, the results presented here demonstrate
that tethering/slow surface translocation of platelets at sites
of arterial injury in vivo is largely inhibited in the absence
of functional GPVI although expression and function of
GPIb-V-IX is not altered under these experimental condi-
tions (Figs. 2 and 3; reference 11). On the other hand, in-
hibition of the vWf binding site on GPIb  by Fab frag-
ments of the p0p/B mAb also virtually abrogated platelet
adhesion to the injured vessel wall, confirming the strict re-
quirement for this interaction under conditions of high
shear in mice (Fig. 2 e). Thus, it appears that GPIb  and
GPVI act in concert to recruit platelets to the subendothe-
lium in vivo by yet undefined mechanisms. This strongly
suggests that presentation of vWf on the extracellular ma-
trix of the damaged vessel wall may differ significantly from
the conditions found in vitro when it is homogeneously
coated to a glass surface. At sites of vascular injury, vWf is
thought to become immobilized mostly on fibrillar col-
lagen (1, 5). Based on our results, one may speculate that
the vWf layer on collagen fibrills might be inhomogeneous
and frequently interrupted making efficient interactions be-
tween GPIb  and vWf impossible unless a second receptor
interacts with the “gaps,” i.e., collagen not covered with
vWf. GPVI is known to be a low affinity collagen receptor
mediating loose, but not firm adhesion that may support
this hypothesis (14, 16). Another point in favor of the idea
that GPIb and GPVI act in concert is the recent identifica-
tion of different snake venom–derived proteins that interact
with platelets specifically through both GPIb and GPVI,
indicating that these two receptors might be physically and
functionally linked (34, 35).
During platelet tethering, ligation of GPVI can shift
 IIb 3 and  2 1 integrins from a low to a high affinity state
(12). Both  IIb 3 and  2 1 then act in concert to promote
subsequent stable arrest of platelets on collagen (5, 12)
whereas  IIb 3 is essential for subsequent aggregation of ad-
herent platelets. Thus, ligation of GPVI during the initial
contact between platelets and subendothelial collagen pro-
vides an activation signal that is essential for subsequent sta-
ble platelet adhesion and aggregation. Our results suggest
that occupation or lateral clustering of GPIb   (during
GPIb -dependent surface translocation), which has been
shown to induce low levels of  IIb 3 integrin activation in
vitro (32), may not be sufficient to promote platelet adhe-
sion in vivo.
This revised model of platelet attachment to the suben-
dothelium highlights a central role of GPVI–collagen inter-
actions in all major phases of thrombus formation, i.e.,
platelet tethering, firm adhesion, and aggregation at sites of
arterial injury (e.g., during acute coronary syndromes). Al-
though the data obtained in mice cannot be directly ex-
trapolated to the situation in humans, the profound anti-
thrombotic protection that was achieved by inhibition or
depletion of GPVI strongly indicates that a selective phar-
macological modulation of GPVI–collagen interactions
may become a promising strategy to control the onset and
progression of pathological arterial thrombosis.
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